3 / 8
Volume 8
Journal of Biotechnology & Biomaterials
ISSN: 2155-952X
Euro Biotechnology 2018
October 11-12, 2018
conference
series
.com
October 11-12, 2018 | Moscow, Russia
21
st
European
Biotechnology Congress
Page 11
Sergey Suchkov, J Biotechnol Biomater 2018, Volume 8
DOI: 10.4172/2155-952X-C5-099
Personalized and Precision Medicine (PPM) as a model of healthcare services of the newest
generation to be promoted via translational applications and biodesign resources
A
newsystems approach todiseased states andwellness result in a newbranch in the healthcare services, namely, personalized
medicine (PM). To achieve the implementation of PM concept into the daily practice including clinical cardiology, it is
necessary to create a fundamentally new strategy based upon the subclinical recognition of bioindicators (biopredictors and
biomarkers) of hidden abnormalities long before the disease clinically manifests itself. Each decision-maker values the impact
of their decision to use PM on their own budget and well-being, which may not necessarily be optimal for society as a whole.
It would be extremely useful to integrate data harvesting from different databanks for applications such as prediction and
personalization of further treatment to thus provide more tailored measures for the patients and persons-at-risk resulting
in improved outcomes whilst securing the healthy state and wellness, reduced adverse events, and more cost effective use of
health care resources. One of the most advanced areas in cardiology is atherosclerosis, cardiovascular and coronary disorders
as well as in myocarditis. A lack of medical guidelines has been identified by the majority of responders as the predominant
barrier for adoption, indicating a need for the development of best practices and guidelines to support the implementation of
PM into the daily practice of cardiologists! Implementation of PM requires a lot before the current model “physician-patient”
could be gradually displaced by a newmodel “medical advisor-healthy person-at-risk”. This is the reason for developing global
sci-entific, clinical, social, and educational projects in the area of PM to elicit the content of the new branch.
Recent Publications
1. T A Bodrova, D S Kostyushev, E N Antonova, Sh. Slavin, D A Gnatenko, M O Bocharova, M Legg, P Pozzilli and S
V Suchkov (2012) Introduction into PPPM as a new paradigm of public health service: an integrative view. EPMA
Journal 3(16):3-16.
2. I A Sadkovsky, O Golubnitschaja, M A Mandrik, M A Studne-va, H Abe, H Schroeder, E N Antono-va, F Betsou, T A
Bodrova, K Payne and S V Suchkov (2014) PPPM (predictive, preventive and personal-ized medicine) as a newmodel
of the na-tional and international healthcare services and thus a promising strategy to prevent a disease: from basics
to practice. International Journal of Clinical Medicine 5:855-870.
3. Zemskov VM, Alekseev A A, Gnatenko DA, Kozlova MN, Shishkina N S, Zemskov AM, Zhegalova I V, Bleykh-man
D A, Bahov N I and Suchkov S V (2016) Overexpression of nitric oxide syn-thase re-stores circulating angiogenic cell
function in patients with coronary artery dis-ease: implications for autologous cell therapy for myocardial infarction.
The Journal of the American Heart Association 5:1-18.
4. Zemskov A, Zemskov V, Zemskova V, Buch T, Cherno-va L Bleykhman D, Marshall T, Abe H, Zhegalova I, Barach
P and Suchkov S (2017) A stepwise screening protocol to secure the module-based treat-ment for managing
immunopathology.
In-ternational Journal of Information Research and Review 4(1):3507-3510.
Sergey Suchkov
I M Sechenov First Moscow State Medical University, Russia